January 22, 2024
2 min watch
Save
VIDEO: Perfluorohexyloctane offers new clinical tool for evaporative dry eye disease
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Laura M. Periman, MD, discusses innovations in evaporative dry eye disease.
“We now have a clinical tool to address the evaporative load of ocular surface disease in real time. This is perfluorohexyloctane,” she said. “It was studied at four times a day in the clinical trials. Clinically, I’m using it two to four times a day. How I explain it to my patient is, ‘This is like Saran wrap for the fruit salad.’”
Published by:
Sources/Disclosures
Collapse
Source:
Periman LM. Breaking the drought: Diagnosing and treating evaporative dry eye disease. Presented at: Hawaiian Eye 2024; Jan. 13-19, 2024; Wailea, Hawaii.
Disclosures:
Periman reports having financial disclosures for Allergan/AbbVie, Bausch + Lomb and Viatris.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.